[PDF][PDF] РАЗРАБОТКА ЭКСПЕРИМЕНТАЛЬНЫХ мРНК-ВАКЦИН ПРОТИВ ГРИППА И COVID-19
ЛИ Карпенко - vector.nsc.ru
Одним из наиболее многообещающих подходов к созданию вакцин против
заболеваний, вызванных высоковариабельными вирусами, является создание вакцин …
заболеваний, вызванных высоковариабельными вирусами, является создание вакцин …
Ethical Issues Involving the Development of COVID-19 Vaccines: Role of Vaccine Development, Clinical Trials, and Speed of Peer Review in Dissuading Public …
LMA Martin, GW Buck - Ethics in Biology, Engineering and …, 2021 - dl.begellhouse.com
Over 60% of the population in the United States received the SARS-Co-V type 2 messenger
RNA (mRNA) vaccine, manufactured by Pfizer-BioNTech and by Moderna. The pace at …
RNA (mRNA) vaccine, manufactured by Pfizer-BioNTech and by Moderna. The pace at …
[PDF][PDF] Article@ Virology
F Nazir, Q Cheng, Z Khalid, T Jin - 2012 - biosky.org
ABSTRACT COVID-19 is a highly contagious novel epidemic that has exploded into the
world's worst health problem in modern history. Since its outbreak in late December 2019 …
world's worst health problem in modern history. Since its outbreak in late December 2019 …
[引用][C] Short title: Ethics of Covid-19 Vaccine Development, Clinical Trials, and Peer Review Ethical Issues Involving the Development of Covid-19 Vaccines: Role of …
LMA Martin, GW Buck
[引用][C] A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 mRNA Vaccine
B Leava, W Strausa, P Whitea, A Leava, T Gainesa…